account_num,net_change,tag,tag_depth,cik
2089,808231000.0,Assets,1,"1438533_TRAVERE THERAPEUTICS, INC."
3645,-488446000.0,LiabilitiesNoncurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
3834,-1100554000.0,RetainedEarningsAccumulatedDeficit,1,"1438533_TRAVERE THERAPEUTICS, INC."
3750,-1291863000.0,AdditionalPaidInCapital,1,"1438533_TRAVERE THERAPEUTICS, INC."
3661,-7000.0,CommonStockValue,3,"1438533_TRAVERE THERAPEUTICS, INC."
3465,-619091000.0,Liabilities,1,"1438533_TRAVERE THERAPEUTICS, INC."
3796,-112472000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,"1438533_TRAVERE THERAPEUTICS, INC."
3379,-26326000.0,OperatingLeaseLiabilityNoncurrent,3,"1438533_TRAVERE THERAPEUTICS, INC."
3303,-375974000.0,LongTermDebtAndCapitalLeaseObligations,2,"1438533_TRAVERE THERAPEUTICS, INC."
3308,-375974000.0,LongTermDebtNoncurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
3154,-130645000.0,LiabilitiesCurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
3017,-5732000.0,OtherLiabilitiesCurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
2347,-102493000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,"1438533_TRAVERE THERAPEUTICS, INC."
3316,-189140000.0,StockholdersEquity,1,"1438533_TRAVERE THERAPEUTICS, INC."
645,161376000.0,CashAndCashEquivalentsAtCarryingValue,3,"1438533_TRAVERE THERAPEUTICS, INC."
577,161376000.0,CashCashEquivalentsAndShortTermInvestments,4,"1438533_TRAVERE THERAPEUTICS, INC."
229,21537000.0,AccountsReceivableNetCurrent,3,"1438533_TRAVERE THERAPEUTICS, INC."
207,21537000.0,AccountsNotesAndLoansReceivableNetCurrent,4,"1438533_TRAVERE THERAPEUTICS, INC."
320,21537000.0,ReceivablesNetCurrent,3,"1438533_TRAVERE THERAPEUTICS, INC."
455,6712000.0,InventoryNet,2,"1438533_TRAVERE THERAPEUTICS, INC."
260,6712000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,"1438533_TRAVERE THERAPEUTICS, INC."
868,604904000.0,AssetsCurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
1634,20289000.0,OperatingLeaseRightOfUseAsset,2,"1438533_TRAVERE THERAPEUTICS, INC."
1368,9127000.0,PropertyPlantAndEquipmentNet,4,"1438533_TRAVERE THERAPEUTICS, INC."
1732,162883000.0,IntangibleAssetsNetExcludingGoodwill,2,"1438533_TRAVERE THERAPEUTICS, INC."
1827,162883000.0,IntangibleAssetsNetIncludingGoodwill,2,"1438533_TRAVERE THERAPEUTICS, INC."
2041,11028000.0,OtherAssetsNoncurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
2091,203327000.0,AssetsNoncurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
3260,-189140000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,"1438533_TRAVERE THERAPEUTICS, INC."
3917,-808231000.0,LiabilitiesAndStockholdersEquity,2,"1438533_TRAVERE THERAPEUTICS, INC."
232,-5125000.0,GrossProfit,1,"1438533_TRAVERE THERAPEUTICS, INC."
144,5125000.0,CostOfRevenue,1,"1438533_TRAVERE THERAPEUTICS, INC."
171,5125000.0,CostOfGoodsAndServicesSold,2,"1438533_TRAVERE THERAPEUTICS, INC."
3809,-2176000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,"1438533_TRAVERE THERAPEUTICS, INC."
3494,-9068000.0,OtherLiabilitiesNoncurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
2552,-85766000.0,AccruedLiabilitiesCurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
2903,-86331000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,"1438533_TRAVERE THERAPEUTICS, INC."
2590,-86331000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,"1438533_TRAVERE THERAPEUTICS, INC."
1912,-86331000.0,NetIncomeLoss,1,"1438533_TRAVERE THERAPEUTICS, INC."
1077,-86331000.0,ProfitLoss,2,"1438533_TRAVERE THERAPEUTICS, INC."
1820,-86331000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,"1438533_TRAVERE THERAPEUTICS, INC."
2399,78000.0,IncomeTaxExpenseBenefit,1,"1438533_TRAVERE THERAPEUTICS, INC."
2257,-86253000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,"1438533_TRAVERE THERAPEUTICS, INC."
2149,-87839000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,"1438533_TRAVERE THERAPEUTICS, INC."
2130,-793000.0,NonoperatingIncomeExpense,1,"1438533_TRAVERE THERAPEUTICS, INC."
1205,-3646000.0,InvestmentIncomeNonoperating,2,"1438533_TRAVERE THERAPEUTICS, INC."
1665,-3646000.0,InvestmentIncomeNet,2,"1438533_TRAVERE THERAPEUTICS, INC."
1563,-3646000.0,InvestmentIncomeInterestAndDividend,3,"1438533_TRAVERE THERAPEUTICS, INC."
1340,-3646000.0,InvestmentIncomeInterest,2,"1438533_TRAVERE THERAPEUTICS, INC."
1264,-87046000.0,OperatingIncomeLoss,1,"1438533_TRAVERE THERAPEUTICS, INC."
1112,132158000.0,OperatingExpenses,1,"1438533_TRAVERE THERAPEUTICS, INC."
601,72245000.0,SellingGeneralAndAdministrativeExpense,3,"1438533_TRAVERE THERAPEUTICS, INC."
491,59913000.0,ResearchAndDevelopmentExpense,2,"1438533_TRAVERE THERAPEUTICS, INC."
581,59913000.0,OperatingCostsAndExpenses,2,"1438533_TRAVERE THERAPEUTICS, INC."
2004,-87000.0,OtherNonoperatingIncomeExpense,1,"1438533_TRAVERE THERAPEUTICS, INC."
110,-56993000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,"1438533_TRAVERE THERAPEUTICS, INC."
3295,-375974000.0,ConvertibleDebtNoncurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
375,59913000.0,ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost,2,"1438533_TRAVERE THERAPEUTICS, INC."
2676,-6900000.0,BusinessCombinationContingentConsiderationLiabilityCurrent,4,"1438533_TRAVERE THERAPEUTICS, INC."
3315,-68300000.0,BusinessCombinationContingentConsiderationLiabilityNoncurrent,4,"1438533_TRAVERE THERAPEUTICS, INC."
2764,-10975000.0,ContractWithCustomerLiabilityCurrent,3,"1438533_TRAVERE THERAPEUTICS, INC."
3279,-8778000.0,DeferredRevenueNoncurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
3339,-8778000.0,ContractWithCustomerLiabilityNoncurrent,3,"1438533_TRAVERE THERAPEUTICS, INC."
2710,-10975000.0,DeferredRevenueCurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
2603,-56993000.0,NoninterestIncome,1,"1438533_TRAVERE THERAPEUTICS, INC."
2398,-16727000.0,AccountsPayableCurrent,2,"1438533_TRAVERE THERAPEUTICS, INC."
